Cargando…
Understanding if, How, and Why Women with Prior Spontaneous Preterm Births are Treated with Progestogens: A National Survey of Obstetrician Practice Patterns
Objective In 2017, the Society for Maternal-Fetal Medicine (SMFM) Guideline Committee reaffirmed that 17 α -hydroxyprogesterone caproate (17-OHPC) to prevent preterm birth (PTB) is underutilized. We sought to determine what drove progestogen treatment choice of obstetricians managing pregnant women...
Autores principales: | Gallagher, Jack R., Gudeman, Jennifer, Heap, Kylee, Vink, Joy, Carroll, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical Publishers
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212295/ https://www.ncbi.nlm.nih.gov/pubmed/30393580 http://dx.doi.org/10.1055/s-0038-1675556 |
Ejemplares similares
-
Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birth
por: Sibai, Baha, et al.
Publicado: (2020) -
Progestogens to prevent preterm birth in twin pregnancies: an individual participant data meta-analysis of randomized trials
por: Schuit, Ewoud, et al.
Publicado: (2012) -
FIGO good practice recommendations on progestogens for prevention of preterm delivery
por: Shennan, Andrew, et al.
Publicado: (2021) -
Progesterone and progestogens
por: Lipinski, Joanne
Publicado: (2022) -
Genome-wide association studies in preterm birth: implications for the practicing obstetrician-gynaecologist
por: Dolan, Siobhan M, et al.
Publicado: (2013)